<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
49702-210-17
</NDCCode>
<PackageDescription>
180 TABLET in 1 BOTTLE (49702-210-17)
</PackageDescription>
<NDC11Code>
49702-0210-17
</NDC11Code>
<ProductNDC>
49702-210
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Rescriptor
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Delavirdine Mesylate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20101013
</StartMarketingDate>
<EndMarketingDate>
20161231
</EndMarketingDate>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA020705
</ApplicationNumber>
<LabelerName>
ViiV Healthcare Company
</LabelerName>
<SubstanceName>
DELAVIRDINE MESYLATE
</SubstanceName>
<StrengthNumber>
200
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2017-01-05
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>